125 related articles for article (PubMed ID: 11195699)
1. The antibiotics crisis. We're in the midst of an escalating arms race with the microbe, and we may be losing.
Nash JM
Time; 2001 Jan; 157(2):90-2. PubMed ID: 11195699
[No Abstract] [Full Text] [Related]
2. Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides.
Hoffman-Roberts HL; Obritsch MD; Bronze MS; Greenfield RA
J Okla State Med Assoc; 2007 Apr; 100(4):105-11. PubMed ID: 17476993
[No Abstract] [Full Text] [Related]
3. Synthesis of novel tricyclic oxazolidinones by a tandem SN2 and SNAr reaction: SAR studies on conformationally constrained analogues of Linezolid.
Selvakumar N; Yadi Reddy B; Sunil Kumar G; Khera MK; Srinivas D; Sitaram Kumar M; Das J; Iqbal J; Trehan S
Bioorg Med Chem Lett; 2006 Aug; 16(16):4416-9. PubMed ID: 16781153
[TBL] [Abstract][Full Text] [Related]
4. Design at the atomic level: generation of novel hybrid biaryloxazolidinones as promising new antibiotics.
Zhou J; Bhattacharjee A; Chen S; Chen Y; Duffy E; Farmer J; Goldberg J; Hanselmann R; Ippolito JA; Lou R; Orbin A; Oyelere A; Salvino J; Springer D; Tran J; Wang D; Wu Y; Johnson G
Bioorg Med Chem Lett; 2008 Dec; 18(23):6179-83. PubMed ID: 18951792
[TBL] [Abstract][Full Text] [Related]
5. [Linezolid, an agent from a new class of antibiotics].
Slebos DJ; Van Altena R
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2462; author reply 2462-3. PubMed ID: 15626313
[No Abstract] [Full Text] [Related]
6. Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics.
Zhou J; Bhattacharjee A; Chen S; Chen Y; Duffy E; Farmer J; Goldberg J; Hanselmann R; Ippolito JA; Lou R; Orbin A; Oyelere A; Salvino J; Springer D; Tran J; Wang D; Wu Y; Johnson G
Bioorg Med Chem Lett; 2008 Dec; 18(23):6175-8. PubMed ID: 18947996
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid.
D'Andrea S; Zheng ZB; Denbleyker K; Fung-Tomc JC; Yang H; Clark J; Taylor D; Bronson J
Bioorg Med Chem Lett; 2005 Jun; 15(11):2834-9. PubMed ID: 15911264
[TBL] [Abstract][Full Text] [Related]
8. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.
Johnson AP; Mushtaq S; Warner M; Livermore DM
Int J Antimicrob Agents; 2004 Oct; 24(4):315-9. PubMed ID: 15380254
[TBL] [Abstract][Full Text] [Related]
9. Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections.
Ament PW; Jamshed N; Horne JP
Am Fam Physician; 2002 Feb; 65(4):663-70. PubMed ID: 11871684
[TBL] [Abstract][Full Text] [Related]
10. Getting the right drug into the right patient.
Marshall A
Nat Biotechnol; 1997 Nov; 15(12):1249-52. PubMed ID: 9359105
[No Abstract] [Full Text] [Related]
11. Drugs for MRSA with reduced susceptibility to vancomycin.
Med Lett Drugs Ther; 2009 May; 51(1311):36; quiz 37. PubMed ID: 19417720
[No Abstract] [Full Text] [Related]
12. The new antibiotics.
Breithaupt H
Nat Biotechnol; 1999 Dec; 17(12):1165-9. PubMed ID: 10585711
[No Abstract] [Full Text] [Related]
13. Synthesis and in vitro antibacterial activities of novel oxazolidinones.
Srivastava BK; Jain MR; Solanki M; Soni R; Valani D; Gupta S; Mishra B; Takale V; Kapadnis P; Patel H; Pandya P; Patel JZ; Patel PR
Eur J Med Chem; 2008 Apr; 43(4):683-93. PubMed ID: 17611001
[TBL] [Abstract][Full Text] [Related]
14. N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
Mishra RK; Revell KD; Coates CM; Turos E; Dickey S; Lim DV
Bioorg Med Chem Lett; 2006 Apr; 16(8):2081-3. PubMed ID: 16464583
[TBL] [Abstract][Full Text] [Related]
15. The tragedy of the commons in antimicrobial chemotherapy.
Baquero F; Campos J
Rev Esp Quimioter; 2003 Mar; 16(1):11-3. PubMed ID: 12750754
[No Abstract] [Full Text] [Related]
16. [New antibacterial agents].
Vaara M; Saxén H
Duodecim; 1999; 115(20):2259-64. PubMed ID: 11973930
[No Abstract] [Full Text] [Related]
17. Effects of positional and geometrical isomerism on the biological activity of some novel oxazolidinones.
Das J; Rao CV; Sastry TV; Roshaiah M; Sankar PG; Khadeer A; Kumar MS; Mallik A; Selvakumar N; Iqbal J; Trehan S
Bioorg Med Chem Lett; 2005 Jan; 15(2):337-43. PubMed ID: 15603950
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial activities of novel oxazolidinones having spiro[2,4]heptane moieties.
Kim SY; Park HB; Cho JH; Yoo KH; Oh CH
Bioorg Med Chem Lett; 2009 May; 19(9):2558-61. PubMed ID: 19345578
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic challenges in the era of antibiotic resistance.
Lee C
Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S197-9. PubMed ID: 19134519
[TBL] [Abstract][Full Text] [Related]
20. [Linezolid, a drug in a new class of antibiotics].
Knudsen JD; Skov RL
Ugeskr Laeger; 2003 Mar; 165(13):1349-53. PubMed ID: 12703280
[No Abstract] [Full Text] [Related]
[Next] [New Search]
